997
Views
14
CrossRef citations to date
0
Altmetric
Review

Controlling serogroup B invasive meningococcal disease: the Canadian perspective

, , , &
Pages 505-517 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Parvanè Kuhdari, Armando Stefanati, Silvia Lupi, Nicoletta Valente & Giovanni Gabutti. (2016) Meningococcal B vaccination: real-world experience and future perspectives. Pathogens and Global Health 110:4-5, pages 148-156.
Read now
Cosmina Hogea, Thierry Van Effelterre & Andrew Vyse. (2016) Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement. Human Vaccines & Immunotherapeutics 12:2, pages 451-466.
Read now
Marco Aurélio Sáfadi, Julie A Bettinger, Gabriela Moreno Maturana, Godwin Enwere & Ray Borrow. (2015) Evolving meningococcal immunization strategies. Expert Review of Vaccines 14:4, pages 505-517.
Read now
Roberto Gasparini, Daniela Amicizia, Alexander Domnich, Piero Luigi Lai & Donatella Panatto. (2014) Neisseria meningitidis B vaccines: recent advances and possible immunization policies. Expert Review of Vaccines 13:3, pages 345-364.
Read now
Patricia Kaaijk, Arie van der Ende & Willem Luytjes. (2014) Routine vaccination against MenB. Human Vaccines & Immunotherapeutics 10:2, pages 310-316.
Read now

Articles from other publishers (9)

Alessia Biolchi, Gabriella De Angelis, Monica Moschioni, Sara Tomei, Brunella Brunelli, Maria Giuliani, Stefania Bambini, Ray Borrow, Heike Claus, Maria Cecilia O. Gorla, Eva Hong, Ana Paula S. Lemos, Jay Lucidarme, Muhamed-Kheir Taha, Ulrich Vogel, Maurizio Comanducci, Sonia Budroni, Marzia M. Giuliani, Rino Rappuoli, Mariagrazia Pizza & Philip Boucher. (2020) Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates. Vaccine 38:47, pages 7542-7550.
Crossref
Philippe De Wals. (2019) Epidemiology and Control of Meningococcal Disease in Canada: A Long, Complex, and Unfinished Story. Canadian Journal of Infectious Diseases and Medical Microbiology 2019, pages 1-11.
Crossref
Thomas W. Bourke, James P. McKenna, Peter V. Coyle, Derek J. Fairley & Michael D. Shields. (2016) Genomic Meningococcal Load in the Nasopharynx of Children with Meningococcal Disease. Pediatric Infectious Disease Journal 35:5, pages 577-579.
Crossref
Philip S. Watson & David P.J. Turner. (2016) Clinical experience with the meningococcal B vaccine, Bexsero ® : Prospects for reducing the burden of meningococcal serogroup B disease. Vaccine 34:7, pages 875-880.
Crossref
Shruti Sridhar, Brian Greenwood, Christopher Head, Stanley A Plotkin, Marco A Sáfadi, Samir Saha, Muhamed-Kheir Taha, Oyewale Tomori & Bradford D Gessner. (2015) Global incidence of serogroup B invasive meningococcal disease: a systematic review. The Lancet Infectious Diseases 15:11, pages 1334-1346.
Crossref
Entesar H. Husain, Mohammad Barakat & Mosaab Al-Saleh. (2015) Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987–2013. Journal of Infection and Public Health 8:5, pages 441-447.
Crossref
Susanna Esposito, Claudia Tagliabue & Samantha Bosis. (2015) Meningococcal B Vaccination (4CMenB) in Infants and Toddlers. Journal of Immunology Research 2015, pages 1-6.
Crossref
Dennis K. S. Law, Jianwei Zhou, Saul Deng, Linda Hoang, Gregory Tyrrell, Greg Horsman, John Wylie & Raymond S. W. Tsang. (2014) Determination of serotyping antigens, clonal analysis and genetic characterization of the 4CMenB vaccine antigen genes in invasive Neisseria meningitidis from Western Canada, 2009 to 2013. Journal of Medical Microbiology 63:11, pages 1490-1499.
Crossref
Miguel O’Ryan, Jeffrey Stoddard, Daniela Toneatto, James Wassil & Peter M. Dull. (2013) A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program. Drugs 74:1, pages 15-30.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.